Directory
>
Evan Feinberg
Evan Feinberg
Research Fellow | Genesis Molecular AI
California, Palo Alto, United States
Evan Feinberg
Summary
Evan Feinberg is a visionary scientist and entrepreneur who is revolutionizing drug discovery at Genesis Therapeutics, Inc. With a Ph.D. from Stanford, he developed cutting-edge deep learning methods for molecular property prediction under the guidance of Vijay Pande. His impressive journey includes significant roles at renowned institutions like Merck and Memorial Sloan Kettering Cancer Center, where he co-invented novel techniques in nanobiotechnology. Evan's academic excellence is underscored by his accolades from Yale University, where he graduated with honors in Applied Physics. He is passionate about harnessing artificial intelligence to enhance drug development processes, and his startup is at the forefront of AI-enabled biotech innovations. Evan's leadership is complemented by a strong technical background in machine learning and biophysics, positioning him uniquely in the intersection of science and technology. Outside of work, he is likely to be found exploring the latest advancements in AI and their applications in healthcare.
Evan Feinberg
Work Experience
Founder and CEO at
Genesis Molecular AI
March 2019 - Present
Evan Feinberg
Education
Stanford University, Doctor of Philosophy (Ph.D.), Biophysics
January 2013 - January 2018
Yale University, Bachelor of Science (B.S.), Applied Physics
January 2009 - January 2013
Frequently Asked Questions about Evan Feinberg
What is Evan Feinberg email address?
Evan Feinberg's primary email address is ****@genesistherapeutics.ai. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Evan Feinberg work for?
Evan Feinberg is a Research Fellow at Genesis Molecular AI.
Where Evan Feinberg graduated from?
Evan Feinberg holds a degree in Adviser: Vijay S. Pande Deep learning methods development PyTorch and Tensorflow implementation Molecular dynamics simulation Massively parallel molecular docking Discovered experimentally active, novel GPCR chemotypes from Stanford University.
How can I directly contact Evan Feinberg?
To contact Evan Feinberg directly, you can use the email address ****@genesistherapeutics.ai. Complete contact information is available upon registration with Muraena.
Who is Evan Feinberg?
Evan Feinberg is a visionary scientist and entrepreneur who is revolutionizing drug discovery at Genesis Therapeutics, Inc. With a Ph.D. from Stanford, he developed cutting-edge deep learning methods for molecular property prediction under the guidance of Vijay Pande. His impressive journey includes significant roles at renowned institutions like Merck and Memorial Sloan Kettering Cancer Center, where he co-invented novel techniques in nanobiotechnology. Evan's academic excellence is underscored by his accolades from Yale University, where he graduated with honors in Applied Physics. He is passionate about harnessing artificial intelligence to enhance drug development processes, and his startup is at the forefront of AI-enabled biotech innovations. Evan's leadership is complemented by a strong technical background in machine learning and biophysics, positioning him uniquely in the intersection of science and technology. Outside of work, he is likely to be found exploring the latest advancements in AI and their applications in healthcare.
Evan`s contact details
****@genesistherapeutics.ai
****@welcometothejungle.com
***@stanford.edu
*********@mskcc.org
*************@yale.edu
*************@merck.com
Colleagues
Research Associate
Postdoctoral Associate
Post-Doc
Executive Director
Sr.Director Med. Chem.